Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CA 19-9 antibody

This Mouse Monoclonal antibody specifically detects CA 19-9 in ELISA, FACS, IHC (p), WB and IHC (fro). It exhibits reactivity toward Human and has been mentioned in 6+ publications.
Catalog No. ABIN1042585

Quick Overview for CA 19-9 antibody (ABIN1042585)

Target

See all CA 19-9 Antibodies
CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))

Reactivity

  • 42
  • 1
  • 1
Human

Host

  • 27
  • 15
  • 2
Mouse

Clonality

  • 41
  • 2
Monoclonal

Conjugate

  • 27
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CA 19-9 antibody is un-conjugated

Application

  • 27
  • 17
  • 16
  • 15
  • 8
  • 7
  • 7
  • 6
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro))

Clone

121SLE
  • Purification

    IgM specific affinity chromatography

    Immunogen

    Ten precipitin lines obtained after immunodiffusion using monoclonal antibody NS 19-9 and mucins isolated from an ovarian cyst of a OLe (a+b-) patient

    Isotype

    IgM
  • Application Notes

    Optimal antibody dilution should be determined by titration, however as a guideline try at 2 μg/mL on FFPE tissue

    Comment

    Myeloma, fusion partners: Spleen cells from immunised BALB/c mice were fused with cells of the Sp2/0 myeloma line

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    Purified antibody in phosphate buffered saline containing 10 mM sodium azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Partyka, Maupin, Brand, Haab: "Diverse monoclonal antibodies against the CA 19-9 antigen show variation in binding specificity with consequences for clinical interpretation." in: Proteomics, Vol. 12, Issue 13, pp. 2212-20, (2012) (PubMed).

    Schnegelsberg, Schumacher, Valentiner: "Lectin histochemistry of metastasizing and non-metastasizing breast and colon cancer cells." in: Anticancer research, Vol. 31, Issue 5, pp. 1589-97, (2011) (PubMed).

    Shi, Gao, Wang, Wang, Tian, Zhu, Shen, Qin: "CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity." in: World journal of gastroenterology : WJG, Vol. 17, Issue 24, pp. 2965-71, (2011) (PubMed).

    Köhler, Ullrich, Richter, Schumacher: "E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung." in: British journal of cancer, Vol. 102, Issue 3, pp. 602-9, (2010) (PubMed).

    Rye, Bovin, Vlasova, Molodyk, Baryshnikov, Kreutz, Garinther, Schultes, Noujaim, Madiyalakan, Magnani, Nilsson, Nilsson, Nustad, Norum, Bell, Cao, Suresh, Very, Freeman, Yeung, Hilgers: "Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997." in: Tumour biology, Vol. 19, Issue 5, pp. 390-420, (1998) (PubMed).

    Bara, Mollicone, Herrero-Zabaleta, Gautier, Daher, Oriol: "Ectopic expression of the Y (Ley) antigen defined by monoclonal antibody 12-4LE in distal colonic adenocarcinomas." in: International journal of cancer. Journal international du cancer, Vol. 41, Issue 5, pp. 683-9, (1988) (PubMed).

  • Target

    CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))

    Alternative Name

    CA19-9   

    Background

    Synonyms:
    Sialyl Lewis (a) antibody,Sialyl Lewis(a) antibody,Sialyl Lewisa antibody
You are here:
Chat with us!